Frequently Asked Questions

Studies published at the time of abstract submission will be rejected. If the abstract is submitted with a paper to IMMEM in the spring and then published after submission, it will not be rejected. Presenters should add new or unpublished data as an addition to their presentation at IMMEM XIII which did not make it into the paper to keep it fresh and the most up-to-date.

Video abstracts will not be possible for submission to IMMEM XIII.

IMMEM does not have a focus on clinical trials in general or on the development of therapeutics. As such, it is not the platform to present trials in progress either.